Eris Lifesciences has announced a board meeting scheduled for November 12, 2025, to review and approve the unaudited financial results for the quarter and half-year ended September 30, 2025. The trading window for company shares has been closed since October 1, 2025, and will remain closed until 48 hours after the results are declared.
Board Meeting Announcement
A meeting of the Board of Directors of Eris Lifesciences Limited is scheduled for Wednesday, November 12, 2025. During this meeting, the board will consider and approve the standalone and consolidated unaudited financial results for the quarter and half year which concluded on September 30, 2025.
Trading Window Closure
As per the previous notification dated September 26, 2025, the trading window for the company’s shares has been closed since October 1, 2025. This closure will remain in effect until 48 hours after the official declaration of the financial results. This measure complies with company policy and the Prohibition of Insider Trading Regulations.
Source: BSE
